Albrecht, Philipp; Henke, Nadine; Mai-Ly Tran Tien, ? et al.
Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicityNEUROCHEMISTRY INTERNATIONAL. Bd. 62. H. 5. 2013 S. 610-619
Bosmann, M; Grailer, JJ; Ruemmler, R et al.
Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injuryThe FASEB Journal. Bd. 27. H. 12. 2013 S. 5010-21
Bosmann, Markus; Grailer, Jamison J.; Ruemmler, Robert et al.
Extracellular histones are essential effectors of C5aR-and C5L2-mediated tissue damage and inflammation in acute lung injuryFASEB JOURNAL. Bd. 27. H. 12. 2013 S. 5010-5021
Oldhafer, Karl J.; Stavrou, Gregor A.; Donati, Marcello et al.
Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters - a case seriesWORLD JOURNAL OF SURGICAL ONCOLOGY. Bd. 11. 2013
Gessi, Marco; Gielen, Gerrit H.; Roeder-Geyer, Eva-Dorette et al.
Extracranial metastasizing solitary fibrous tumors (SFT) of meninges: Histopathological features of a case with long-term follow-upNEUROPATHOLOGY. Bd. 33. H. 1. 2013 S. 68-74
Sprinzl, Martin F.; Galle, Peter R.
Facing the dawn of immunotherapy for hepatocellular carcinomaJOURNAL OF HEPATOLOGY. Bd. 59. H. 1. 2013 S. 9-10
Stein, Jamal M.; Yekta, Sareh Said; Kleines, Michael et al.
Failure to detect an association between aggressive periodontitis and the prevalence of herpesvirusesJOURNAL OF CLINICAL PERIODONTOLOGY. Bd. 40. H. 1. 2013 S. 1-7
Zeuzem, Stefan; Soriano, Vincent; Asselah, Tarik et al.
Faldaprevir and Deleobuvir for HCV Genotype 1 InfectionNEW ENGLAND JOURNAL OF MEDICINE. Bd. 369. H. 7. 2013 S. 630-639
Sulkowski, Mark S.; Bourliere, Marc; Bronowicki, Jean-Pierre et al.
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trialHEPATOLOGY. Bd. 57. H. 6. 2013 S. 2155-2163
Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob et al.
Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic genotype1 HCV: SILEN-C1 trialHEPATOLOGY. Bd. 57. H. 6. 2013 S. 2143-2154